Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The K+ channel, one of the determinants for neuronal excitability, is genetically heterogeneous, and various K+ channel genes are expressed in the CNS. The therapeutic potential of K+ channel blockers for cognitive enhancement has been discussed, but the contribution each K+ channel gene makes to cognitive function remains obscure.
BEC1
(KCNH3) is a member of the K+ channel superfamily that shows forebrain-preferential distribution. Here, we show the critical involvement of
BEC1
in cognitive function.
BEC1
knock-out mice performed behavioral tasks related to working memory, reference memory, and attention better than their wild-type littermates. Enhanced performance was also observed in heterozygous mutants. The knock-out mice had neither the
seizures
nor the motor dysfunction that are often observed in K+ channel-deficient mice. In contrast to when it is disrupted, overexpression of
BEC1
in the forebrain caused the impaired performance of those tasks. It was also found that altering
BEC1
expression could change hippocampal neuronal excitability and synaptic plasticity. The results indicate that
BEC1
may represent the first K+ channel that contributes preferentially and bidirectionally to cognitive function.
...
PMID:Disruption of the ether-a-go-go K+ channel gene BEC1/KCNH3 enhances cognitive function. 1992 96